Seeing Is Believing
Healthcare - Sector
KRYS is currently covered by 8 analysts with an average price target of $259.41. This is a potential upside of $42.44 (19.56%) from yesterday's end of day stock price of $216.97.
Krystal Biotech's activity chart (see below) currently has 115 price targets and 98 ratings on display. The stock rating distribution of KRYS is 88.89% BUY and 11.11% HOLD.
Analysts average stock forecasts to be materialized ratio is 85.97% with an average time for these price targets to be met of 286.42 days.
Highest price target for KRYS is $255, Lowest price target is $189, average price target is $213.5.
Most recent stock forecast was given by GEULAH LIVSHITS from CHARDAN CAPITAL on 03-Nov-2025. First documented stock forecast 17-Oct-2017.
Currently out of the existing stock ratings of KRYS, 24 are a BUY (88.89%), 3 are a HOLD (11.11%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$220
$7.98 (3.76%)
$216
22 days ago
(03-Nov-2025)
9/15 (60%)
$22.15 (11.20%)
394
Hold
$198
$-14.02 (-6.61%)
$166
22 days ago
(03-Nov-2025)
5/6 (83.33%)
$0.15 (0.08%)
206
Buy
$255
$42.98 (20.27%)
$192
1 months 9 days ago
(16-Oct-2025)
3/4 (75%)
$64.77 (34.05%)
284
Buy
$240
$27.98 (13.20%)
$240
2 months 11 days ago
(14-Sep-2025)
24/36 (66.67%)
$84.29 (54.13%)
210
Buy
$202
$-10.02 (-4.73%)
$130
6 months 19 days ago
(06-May-2025)
5/5 (100%)
$65.2 (47.66%)
319
What is KRYS (Krystal Biotech) average time for price targets to be met?
Which analyst has the current highest performing score on KRYS (Krystal Biotech) with a proven track record?
Which analyst has the most public recommendations on KRYS (Krystal Biotech)?
Which analyst is the currently most bullish on KRYS (Krystal Biotech)?
Which analyst is the currently most reserved on KRYS (Krystal Biotech)?